Case Report
BibTex RIS Cite

Germ cell testicular tumor with best prognosis, spermatocytic seminoma: a rare case report

Year 2019, , 146 - 148, 22.09.2019
https://doi.org/10.32322/jhsm.453505

Abstract

The spermatocytic seminoma is a different testicular
germ cell neoplasm representing less than 1% of testicular cancers. It has
distinctive clinical and pathological features when compared with classical
seminoma. Diagnosis of spermatocytic seminoma is difficult, especially in
elderly patients, due to its rare occurrence, lack of clinical presentation,
and the difficulty of differential diagnosis with morphologically testicular
lymphoma and classical seminoma. Here we present the clinical presentation,
histopathologic features and prognosis of a spermatocytic seminoma case in the
light of literature information.

References

  • 1. Talerman A: Spermatocytic seminoma: clinicopathological study of 22 cases. Cancer 1980, 15:2169–2176.
  • 2. Rosai J, Nochomovitz LE: Current concepts of the histogenesis, pathology, and immunocytochemistry of germ cell tumors of the testis. Parhol Annu 1978, 13:335–338.
  • 3. Floyd C, Ayala AG, Logothetis CJ, Silva EG: Spermatocytic seminoma with associated sarcoma of the testis. Cancer 1988, 15:409–414.
  • 4. Carrière P, Baade P, Fritschi L: Population based incidence and age distribution of spermatocytic seminoma. J Urol 2007, 178:125–128.
  • 5. Masson P: A study of seminomas. Rev Cunud B id 1946,5:361–387.
  • 6. Dundr P, Pesl M, Povýsil C, Prokopová P, Pavlík I, Soukup V, Dvorácek J: Anaplastic variant of spermatocytic seminoma. Pathol Res Pract 2007, 203:621–624.
  • 7. Chelly I, Mekni A, Gargouri MM, Bellil K, Zitouna M, Horchani A, Kchir N: Spermatocytic seminoma with rhabdomyosarcomatous contigent. Prog Urol 2006, 16:218-220.
  • 8.Rosai J, Silber I, Khodadoust K: Spermatocytic seminoma. Clinicopathologic study of six cases and review of the literature. Cancer 1969, 24:92-102.
  • 9. Burke AP, Mostofi FK: Spermatocytic seminoma: a clinicopathololgic studyof 79 cases. J Urol Pathol 1993, 1:21-32.
  • 10. Carrière P, Peter B, Lin F: From the Viertel Centre for Research in Cancer Control, Brisbane, Queensland (PC, PB), and WesternAustralian Institute for Medical Research, Perth (LF), Australia.
  • 11. Van Gurp R, De Krijger R, Geurts Van Kessel A, Köberle B, Oosterhuis Stoop W, Looijenga L: Reactivity of germ cell maturation stagespecific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest 2001, 81:919–928.
  • 12. Looijenga LH, Hersmus R, Gillis AJ, Pfundt R, Stoop HJ, Van Gurp RJ et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 2006, 66:290–302.
  • 13. Chung PW, Bayley AJ, Sweet J, Jewett MA, Tew-George B, Gospodarowicz MK,Warde PR: Spermatocytic seminoma: a review. Eur Urol 2004, 45:495–498
  • 14. Raiss GG, Benatiya Andaloussi MM, Raissouni SS, Mrabti HH, Errihani HH: Spermatocytic seminoma at the national institute of oncology in Morocco. BMC Res Notes 2011, 29(4):218.
  • 15. Oosterhuis JW, Looijenga LH: Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005, 5:210–222.
  • 16. Cummings OW, Ulbright TM, Eble JN, et al: Spermatocytic seminoma: animmunohistochemical study. Hum Pathol 1994, 25:54-59.
  • 17. Albores-Saavedra J, Huffman H, Alvarado-Cabrero I, Ayala AG: Anaplasticvariant of spermatocytic seminoma. Hum Pathol 1996, 27:650-655.
  • 18. Steiner H, Gozzi C, Verdorfer I, Mikuz G, Bartsch G, Hobisch A: Metastaticspermatocytic seminoma - an extremely rare disease. Eur Urol 2006,49:183-186.
  • 19. Trivedi P, Pasricha S, Gupta A: Spermatocytic seminoma associated withundifferentiated sarcoma: a rare case report. Indian J Pathol Microbiol2011, 54:138-140.
  • 20. Narang V, Gupta K, Gupta A, Kumar S: Rhabdomyosarcomatous differentiation in a spermatocytic seminoma with review of literature. Indian J Urol 2012, 28:430–433.

En iyi prognozlu, spermatocytic seminomlu germ hücreli testis tümörü: nadir bir olgu sunumu

Year 2019, , 146 - 148, 22.09.2019
https://doi.org/10.32322/jhsm.453505

Abstract

Spermatocytic
seminom, testiküler kanserlerin %1'inden azını temsil eden farklı bir
testiküler germ hücreli neoplazmdır. Klasik seminomla karşılaştırıldığında
belirgin klinik ve patolojik özelliklere sahiptir. Spermatocytic seminom
tanısı, özellikle yaşlı hastalarda, nadir görülmesi, klinik prezentasyonun
olmaması ve morfolojik testiküler lenfoma ve klasik seminom ile ayırıcı tanıda
zorluğundan dolayı zordur. Burada literatür bilgileri ışığında bir
spermatocytic seminom vakasının klinik prezentasyonu, histopatolojik
özellikleri ve prognozunu sunuyoruz.

References

  • 1. Talerman A: Spermatocytic seminoma: clinicopathological study of 22 cases. Cancer 1980, 15:2169–2176.
  • 2. Rosai J, Nochomovitz LE: Current concepts of the histogenesis, pathology, and immunocytochemistry of germ cell tumors of the testis. Parhol Annu 1978, 13:335–338.
  • 3. Floyd C, Ayala AG, Logothetis CJ, Silva EG: Spermatocytic seminoma with associated sarcoma of the testis. Cancer 1988, 15:409–414.
  • 4. Carrière P, Baade P, Fritschi L: Population based incidence and age distribution of spermatocytic seminoma. J Urol 2007, 178:125–128.
  • 5. Masson P: A study of seminomas. Rev Cunud B id 1946,5:361–387.
  • 6. Dundr P, Pesl M, Povýsil C, Prokopová P, Pavlík I, Soukup V, Dvorácek J: Anaplastic variant of spermatocytic seminoma. Pathol Res Pract 2007, 203:621–624.
  • 7. Chelly I, Mekni A, Gargouri MM, Bellil K, Zitouna M, Horchani A, Kchir N: Spermatocytic seminoma with rhabdomyosarcomatous contigent. Prog Urol 2006, 16:218-220.
  • 8.Rosai J, Silber I, Khodadoust K: Spermatocytic seminoma. Clinicopathologic study of six cases and review of the literature. Cancer 1969, 24:92-102.
  • 9. Burke AP, Mostofi FK: Spermatocytic seminoma: a clinicopathololgic studyof 79 cases. J Urol Pathol 1993, 1:21-32.
  • 10. Carrière P, Peter B, Lin F: From the Viertel Centre for Research in Cancer Control, Brisbane, Queensland (PC, PB), and WesternAustralian Institute for Medical Research, Perth (LF), Australia.
  • 11. Van Gurp R, De Krijger R, Geurts Van Kessel A, Köberle B, Oosterhuis Stoop W, Looijenga L: Reactivity of germ cell maturation stagespecific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest 2001, 81:919–928.
  • 12. Looijenga LH, Hersmus R, Gillis AJ, Pfundt R, Stoop HJ, Van Gurp RJ et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 2006, 66:290–302.
  • 13. Chung PW, Bayley AJ, Sweet J, Jewett MA, Tew-George B, Gospodarowicz MK,Warde PR: Spermatocytic seminoma: a review. Eur Urol 2004, 45:495–498
  • 14. Raiss GG, Benatiya Andaloussi MM, Raissouni SS, Mrabti HH, Errihani HH: Spermatocytic seminoma at the national institute of oncology in Morocco. BMC Res Notes 2011, 29(4):218.
  • 15. Oosterhuis JW, Looijenga LH: Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005, 5:210–222.
  • 16. Cummings OW, Ulbright TM, Eble JN, et al: Spermatocytic seminoma: animmunohistochemical study. Hum Pathol 1994, 25:54-59.
  • 17. Albores-Saavedra J, Huffman H, Alvarado-Cabrero I, Ayala AG: Anaplasticvariant of spermatocytic seminoma. Hum Pathol 1996, 27:650-655.
  • 18. Steiner H, Gozzi C, Verdorfer I, Mikuz G, Bartsch G, Hobisch A: Metastaticspermatocytic seminoma - an extremely rare disease. Eur Urol 2006,49:183-186.
  • 19. Trivedi P, Pasricha S, Gupta A: Spermatocytic seminoma associated withundifferentiated sarcoma: a rare case report. Indian J Pathol Microbiol2011, 54:138-140.
  • 20. Narang V, Gupta K, Gupta A, Kumar S: Rhabdomyosarcomatous differentiation in a spermatocytic seminoma with review of literature. Indian J Urol 2012, 28:430–433.
There are 20 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Report
Authors

Mehmet Zengin

Publication Date September 22, 2019
Published in Issue Year 2019

Cite

AMA Zengin M. Germ cell testicular tumor with best prognosis, spermatocytic seminoma: a rare case report. J Health Sci Med / JHSM. September 2019;2(4):146-148. doi:10.32322/jhsm.453505

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.